Drug discovery

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Webinar

Webinar: Where is AI delivering measurable gains for drug discovery?

This webinar, sponsored by Benchling, provides an exclusive readout of what biotech leaders need to know heading into 2026 — and how 100 AI frontrunners are translating AI into real scientific impact. Get a rare, upfront look at what the most advanced biotech teams are actually… Read More

Webinar date:
Supported by Benchling
#News

Metabolomics
#Autoimmune disease #Drug discovery #Lipidomics #Metabolomics #Precision medicine #Webinar

Uncover novel biomarkers using metabolomic and lipidomic profiling

This webinar, hosted by DDW and supported by Evotec, introduces untargeted metabolomics and lipidomics analyses, which are designed to accelerate research in complex biological systems. The webinar begins with an overview of the principles behind untargeted approaches, highlighting their importance in capturing a comprehensive molecular snapshot without prior assumptions. Read More

Webinar date:
Supported by Evotec
#News

3d structure of the protein molecule
#Assays #Biotech #Digital workflow #Drug discovery #Protein #Protein chemistry / Proteomics #Webinar

Webinar: A deep dive into high-throughput protein analysis

In this webinar, Bio-Techne unveils the next evolution of the Leo System, expanding the capabilities of Simple Western Technology for high-throughput protein analysis. The Leo System now supports integrated dual fluorescence channels—Near-Infrared (NIR) and Infrared (IR)—alongside chemiluminescence, enabling simultaneous detection of multiple targets within 96 samples in a single… Read More

#News

#AI #Bayer #Cradle #Drug discovery

Bayer partners with Cradle to advance AI-led drug discovery 

Pharma giant Bayer has signed a three-year strategic collaboration with biotech company Cradle to advance AI-enabled antibody discovery and optimisation.  Bayer aims to implement Cradle’s AI software platform, used for protein engineering, to scale its drug discovery and development efforts. The company intends to integrate Cradle’s platform with existing R&D… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Webinar

How are companies translating AI into real scientific impact?

This webinar, sponsored by Benchling, provides an exclusive readout of what biotech leaders need to know heading into 2026 — and how 100 AI frontrunners are translating AI into real scientific impact. Get a rare, upfront look at what the most advanced biotech teams are actually… Read More

Webinar date:
Supported by Benchling
#News

#Clarivate #Drug discovery

Clarivate’s Drugs to Watch could ‘transform care’ 

Analytics company Clarivate has released its 2026 Drugs to Watch report, with eleven therapies expected to deliver clinical and commercial impact this coming year.  The annual analysis highlights therapies expected to reshape treatment approaches across metabolic disease, oncology, immunology, rare conditions and neurological disorders, with the potential to achieve… Read More

#News

3D protein molecules structure
#Drug discovery #Mass spectrometry / NMR #Protein chemistry / Proteomics #Webinar

Webinar: Practical applications of MS-based targeted proteomics

Mass spectrometry-based targeted proteomics supports each step of drug development, from early discovery to preclinical phases and even clinical phases. Registrations are now open for a new webinar taking place on 29 January 2026, entitled ‘MS-based targeted proteomics: A cornerstone to progress drug development through preclinical and clinical phases‘. Read More

Webinar date:
Supported by Evotec
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug discovery #Webinar

Webinar: The power shift shaping biotech’s AI future

This webinar, sponsored by Benchling, provides an exclusive readout of what biotech leaders need to know heading into 2026 — and how 100 AI frontrunners are translating AI into real scientific impact. Get a rare, upfront look at what the most advanced biotech teams are actually… Read More

Webinar date:
Supported by Benchling
#News

#Autoimmune disease #Drug discovery #Lipidomics #Metabolomics #Precision medicine #Webinar

Webinar: The importance of untargeted approaches to discovery

This webinar, hosted by DDW and supported by Evotec, introduces untargeted metabolomics and lipidomics analyses, which are designed to accelerate research in complex biological systems. The webinar begins with an overview of the principles behind untargeted approaches, highlighting their importance in capturing a comprehensive molecular snapshot without prior assumptions. Read More

Webinar date:
Supported by Evotec
#News

Lab equipment
#Assays #Biotech #Digital workflow #Drug discovery #Protein #Protein chemistry / Proteomics #Webinar

Webinar: Achieve high-throughput, multiplexed protein analysis

In this webinar, Bio-Techne unveils the next evolution of the Leo System, expanding the capabilities of Simple Western Technology for high-throughput protein analysis. The Leo System now supports integrated dual fluorescence channels—Near-Infrared (NIR) and Infrared (IR)—alongside chemiluminescence, enabling simultaneous detection of multiple targets within 96 samples in a single… Read More

#News

#AI #Cell and gene therapy #Charles River #Drug discovery #European Commission #European Union #FDA #Immune cells #Korea #Obesity #Personalised medicine #Rare disease #Regulatory

DDW Highlights: 23 December 2025

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a research team found that a hidden molecular switch fuels obesity. Elsewhere, AI-generated… Read More

#Podcasts

Proteomics
#Drug discovery #Mass spectrometry / NMR #Protein chemistry / Proteomics #Webinar

Webinar: Understand MS-based targeted proteomics

Mass spectrometry-based targeted proteomics supports each step of drug development, from early discovery to preclinical phases and even clinical phases. Registrations are now open for a new webinar taking place on 29 January 2026, entitled ‘MS-based targeted proteomics: A cornerstone to progress drug development through preclinical and clinical phases‘. Read More

Webinar date:
Supported by Evotec
#News

#Artificial intelligence (AI) #Chai Discovery #Drug discovery #Financing

Chai Discovery announces $130m series B financing

Chai Discovery has announced a $130 million Series B financing round co-led by Oak HC/FT and General Catalyst.   The news follows Chai’s most recent announcement, where the company showed its latest models can now design molecules with important “developability” properties and tackle “hard-to-drug” targets that have historically been challenging for… Read More

#Business & Investment #News

Proteomics
#Drug discovery #Mass spectrometry / NMR #Protein chemistry / Proteomics #Webinar

MS-based targeted proteomics: A cornerstone to progress drug development through preclinical and clinical phases

Mass spectrometry-based targeted proteomics supports each step of drug development, from early discovery to preclinical phases and even clinical phases. This webinar, hosted by DDW and supported by Evotec, will cover a diverse set of applications to illustrate how tailored and targeted proteomics fulfils scientific – and even regulatory –… Read More

Webinar date:
Supported by Evotec
#Webinars

#DDW Turning Science into Business Symposium #Drug discovery #Events

DDW Turning Science into Business Symposium features expert panel: Watch now

Technology, market forces and new ways of working – the challenges facing drug discovery and how to overcome them: This was the topic of the panel discussion at the DDW Turning Science into Business Symposium which took place at the Francis Crick Institute in London on Tuesday 4 November. Read More

#News

#AI #Cell and gene therapy #Charles River #Drug discovery #European Commission #European Union #FDA #Immune cells #Korea #Obesity #Personalised medicine #Rare disease #Regulatory

This week in Drug Discovery (15 – 19 December) 

News round-up for 15 – 19 December by Bruno Quinney, Content Team at DDW.  This week in DDW, a research team found that a hidden molecular switch fuels obesity. Elsewhere, AI-generated antibodies have been tolerated by human immune cells.  The top stories:    Scientists discover hidden molecular switch that… Read More

#News